SCHEDULE 13G: Investment Group Discloses Significant Passive Stake in BiomX Inc.

A group of entities and an individual, led by Rodney Hodges, have disclosed a passive beneficial ownership stake of up to 7.6% in BiomX Inc., including warrants, as detailed in a recent Schedule 13G filing.

Summary

• Rodney Hodges, POD Sarl, Geneva Holding Company (GHC) SA, and Geneva Trust Company (GTC) SA collectively reported beneficial ownership of 1,970,403 shares of BiomX Inc. Common Stock, representing 7.6% of the class.
• Centaurus Investments Limited and Telmina Limited, also part of the group, reported beneficial ownership of 1,833,062 shares, representing 7.1% of the class.
• The reported beneficial ownership for all entities includes 644,745 warrants and 255,635 pre-funded warrants held by Telmina Limited, which are exercisable within 60 days of April 21, 2025.
• The percentages of ownership are calculated based on 24,966,053 shares of BiomX Inc. Common Stock outstanding as of April 11, 2025, as reported in the Issuer's Form S-1.
• The filing indicates a passive investment purpose, with the reporting persons certifying that the securities were not acquired or held for the purpose of changing or influencing the control of BiomX Inc.

Sentiment

Score: 5

Explanation: The document is a standard Schedule 13G filing, indicating a passive beneficial ownership stake. It does not contain information that would significantly alter the company's operational or financial outlook, nor does it suggest an activist intent, thus maintaining a neutral sentiment.

Positives

• The disclosure of a significant beneficial ownership stake by a group of entities and an individual may signal confidence in BiomX Inc. from these investors.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding BiomX Inc.'s future performance or strategic direction from the company or the reporting persons.

Management Comments

• Rodney Hodges disclaims beneficial ownership of the shares held by the Reporting Entities except to the extent of his pecuniary interest therein, as he does not make day-to-day voting or investment decisions with respect to those shares.

Industry Context

This Schedule 13G filing is a routine disclosure of a significant passive ownership stake, which is a common occurrence in the public markets. It does not provide specific insights into broader industry trends or competitive dynamics within the biotechnology or microbiome therapeutics sector.

Stakeholder Impact

• Shareholders: The disclosure of a significant passive investor group may provide some level of stability or signal confidence in BiomX Inc., but no direct operational or strategic impact is indicated by this filing.

Key Dates

Keywords

BiomX Inc., BXMX, Schedule 13G, beneficial ownership, passive investment, institutional investor, warrants, common stock, SEC filing